Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2025-12-24 @ 1:29 PM
NCT ID:
NCT04654195
Eligibility Criteria:
Inclusion Criteria:
1. women who has confirmed diagnosis of breast cancer.
2. patient who will be treated with cyclophosphamide and doxorubicin(AC) regimen only .
3. patient take drug regimen for first time.
Exclusion Criteria:
\- 1. Patients with metastatic disease and with other previous tumors were excluded from this study 2. Pregnant or nursing female. 3. The patients who were diagnosed with cardiovascular disease or with low left ventricular ejection fraction.
4 .patients who had benign breast cancers, or had no clinical pathological information
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT04654195
Study Brief:
Protocol Section:
NCT04654195